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Brazil: world leader in anxiety
and depression rates
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On February 23, the World Health Organization (WHO)
published a survey1 on the two most common psychiatric
illnesses affecting the world population: depressive and
anxiety disorders. According to this survey, Brazil leads
the world in prevalence of anxiety disorders and ranks
fifth in depression rates.
Surveys of this kind are highly relevant, as they are
often the basis of actions by the government and society
and serve as guides for public policy-making for preven-
tion and/or treatment. Whatever the use and attention that
the data from this survey might have in the future, some
reflections seem timely for an informed debate on this topic.
Compared to the preceding survey, released in 2005,2
the latest WHO report describes an increase in the fre-
quency of both depressive and anxiety disorders world-
wide, pointing to population growth and increased longevity
as contributing factors for the current picture. Although the
latter factors are always involved in discussions about the
prevalence of any disease, other potential confounders
must be taken into account in this debate, including metho-
dological discrepancies in diagnosis and data recording
across countries, cultural differences in help-seeking beh-
aviors, and differential availability and organization of mental
health services, to name a few.
In 2007, the British Medical Journal invited two eminent
researchers to answer the question ‘‘Is depression over-
diagnosed?’’ in their section ‘‘Head to Head.’’ Advocating
that depression is overdiagnosed as a result of the medi-
calization of sadness, Parker3 stated that ‘‘a low threshold
for diagnosing clinical depression [...] risks normal human
emotional states being treated as illness, challenging the
model’s credibility and risking inappropriate management.’’
In the opposite direction, Hickie4 wrote at the time that
‘‘From a health and economic perspective, we can give a
clear answer – more adults are alive and well, and we can
easily afford to treat more.’’ Both authors supported their
views with solid evidence.
Whatever the precise extent of the problem in Brazil
and around the globe, it is already a collective issue, and
the personal and financial burden of anxiety and depres-
sion demands prompt and coordinated action from the
scientific community and government agencies.
In order to answer some of the questions raised by the
WHO reports on mental health, research efforts should be
directed to three main targets: 1) furthering our under-
standing of the etiological factors of anxiety and depres-
sive disorders; 2) elucidating their social, cultural, and
geographic determinants and impacts; and 3) increasing
diagnostic and therapeutic accuracy. If the spread of these
disorders is not checked – whether through preventative or
therapeutic action – and the needs of affected individuals
are not met, the productivity and social-security systems of
many countries could be seriously jeopardized in the near
future.
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The use of structured and semi-structured diagnostic
instruments allows objective assessment of DSM cate-
gories by professionals involved in child and adolescent
mental health evaluation, which has been essential to the
advancement of clinical and epidemiological research
in the field. Over the years, several semi-structured
diagnostic instruments have been developed and tested
for reliability and validity, such as the Diagnostic Interview
for Children and Adolescents (DICA)1; the Development
and Well-Being Assessment (DAWBA)2; and the Sche-
dule for Affective Disorders and Schizophrenia for School-
age Children (K-SADS).3
The K-SADS is among the most widely used instru-
ments in child and adolescent psychiatry. The first version
was the K-SADS present state (K-SADS-P), developed
by J. Puig-Antich and W. Chambers in 1978. Updates
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and adaptations were published in the following decades:
the K-SADS-P IIIR in accordance to DSM-IIIR criteria, as
well as the K-SADS epidemiologic (K-SADS-E), which
collects lifetime diagnoses for epidemiologic purposes.
After publication of the DSM-IV in 1994, Kaufman, Birmaher,
Brent, Rao, and Ryan introduced the K-SADS present and
lifetime version (K-SADS-PL), which was the most compre-
hensive version developed to date.3 The K-SADS-E and
K-SADS-PL have been translated into Brazilian Portuguese,
and have been used extensively by researchers and clini-
cians ever since.4,5
In 2013, the American Psychiatry Association launched
the fifth edition of the DSM, with relevant changes to the
psychiatric classification of disorders affecting children
and adolescents.6,7 Soon after, a revised version of the
instrument (K-SADS-PL-DSM-5) was developed to keep
the instrument up to date with the new classification
system. However, this instrument has not yet been trans-
lated into Brazilian Portuguese, hindering the advance-
ment of child and adolescent psychiatry research in the
country. On that account, we endeavored to translate the
revised K-SADS-PL-DSM-5 from English into Brazilian
Portuguese.
In this letter, we describe the careful process of
translation of the latest version of the K-SADS-PL, now
updated according to current DSM-5 criteria (K-SADS-PL-
DSM-5), for use in Brazil. We invited specialists in each
diagnostic area covered by the instrument (Table 1) to
translate the respective section. The entire text was
then revised by two child and adolescent psychiatrists
(TBR and CK) and standardized by an independent
professional (RK, a pediatrician and child neurologist
with a background in linguistics). Subsequently, the
translators of each area approved the final version of
the document.
We regard this as a much-needed and relevant accom-
plishment, which should be followed by validation of this
translated version. Scientific research is asymmetrically
scarce in low- and middle-income countries,8 where the
health demands of children and adolescents are mostly
unmet.9 While many factors operate in this equation,
we believe that the availability of up-to-date translated
and validated versions of psychometric instruments
used worldwide is an important step towards equality of
means.
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Table 1 Diagnostic categories covered in K-SADS-PL-DSM-5
Depressive and bipolar related disorders
Depressive disorders
Mania
Disruptive mood dysregulation disorder
Schizophrenia spectrum and other psychotic disorders
Psychosis
Anxiety, obsessive-compulsive, and trauma-related disorders
Panic disorder
Agoraphobia
Separation anxiety disorder
Social anxiety disorder and selective mutism
Specific phobia
Generalized anxiety disorder
Post-traumatic stress disorder
Obsessive-compulsive disorder
Neurodevelopmental, disruptive and conduct disorders
Attention-deficit/hyperactivity disorder
Oppositional defiant disorder
Conduct disorder
Tic disorders
Autism spectrum disorder
Eating disorders and substance-related disorders
Eating disorders
Tobacco use disorder
Alcohol use disorder
Substance use disorder
Others
Enuresis
Encopresis
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